NEW: Premarket Now Starts at 4AM!

We’re excited to announce the extension of premarket and aftermarket hours! Our members now have access to quotes daily from 4:00 AM to 8:00 PM ET — offering greater flexibility and deeper insights into market trends beyond regular trading hours.

Upgrade to FINVIZ*Elite to access premarket quotes »

PODD

Insulet Corporation

Apr 24 • 04:00PM ET

259.38

Dollar change +12.89
Percentage change 5.23	%

Healthcare • Medical Devices • USA • NASD

Peers: DXCM JNJ ABT MDT EW SYK TNDM BSX BAX LIVN

| Held by: VTI VOO VB SPY IVV VO VUG RSP VBK XLV

Scroll to Statements

Index	S&P 500	P/E	44.81	EPS (ttm)	5.79	Insider Own	0.47%	Shs Outstand	70.20M	Perf Week	3.45%
Market Cap	18.22B	Forward P/E	49.37	EPS next Y	5.25	Insider Trans	-5.71%	Shs Float	69.90M	Perf Month	-4.89%
Income	418.30M	PEG	1.77	EPS next Q	0.79	Inst Own	101.83%	Short Float	3.43%	Perf Quarter	-6.43%
Sales	2.07B	P/S	8.79	EPS this Y	29.84%	Inst Trans	-0.36%	Short Ratio	3.01	Perf Half Y	9.68%
Book/sh	17.26	P/B	15.03	EPS next Y	24.88%	ROA	14.74%	Short Interest	2.40M	Perf Year	57.75%
Cash/sh	13.58	P/C	19.11	EPS next 5Y	25.34%	ROE	43.03%	52W Range	160.19 - 289.46	Perf YTD	-0.65%
Dividend Est.	-	P/FCF	59.64	EPS past 5Y	98.82%	ROI	16.42%	52W High	-10.39%	Beta	1.26
Dividend TTM	-	Quick Ratio	2.73	Sales past 5Y	22.98%	Gross Margin	70.48%	52W Low	61.92%	ATR (14)	12.12
Dividend Ex-Date	-	Current Ratio	3.54	EPS Y/Y TTM	101.95%	Oper. Margin	14.91%	RSI (14)	52.30	Volatility	4.20% 4.71%
Employees	3900	Debt/Eq	1.17	Sales Y/Y TTM	22.07%	Profit Margin	20.19%	Recom	1.54	Target Price	321.76
Option/Short	Yes / Yes	LT Debt/Eq	1.10	EPS Q/Q	-6.24%	Payout	0.00%	Rel Volume	0.65	Prev Close	246.49
Sales Surprise	2.57%	EPS Surprise	14.59%	Sales Q/Q	17.20%	Earnings	May 08 AMC	Avg Volume	795.68K	Price	259.38
SMA20	1.97%	SMA50	-1.11%	SMA200	6.26%	Trades		Volume	520,594	Change	5.23%

Date	Action	Analyst	Rating Change	Price Target Change
Mar-06-25	Initiated	RBC Capital Mkts	Outperform	$340
Nov-06-24	Initiated	Bernstein	Outperform	$300
May-30-24	Initiated	Redburn Atlantic	Buy	$235
May-07-24	Upgrade	Wolfe Research	Peer Perform → Outperform	$200
Dec-21-23	Upgrade	Robert W. Baird	Neutral → Outperform	$180 → $238
Dec-04-23	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$185 → $234
Oct-02-23	Upgrade	Jefferies	Hold → Buy	$260 → $240
Aug-21-23	Upgrade	Citigroup	Neutral → Buy	$273 → $265
Aug-21-23	Downgrade	Robert W. Baird	Outperform → Neutral	$320 → $219
May-30-23	Resumed	Morgan Stanley	Equal-Weight	$343
Jan-26-23	Initiated	Wolfe Research	Peer Perform
Nov-04-22	Upgrade	Piper Sandler	Neutral → Overweight	$235 → $340
Oct-18-22	Initiated	Barclays	Equal Weight	$238
Oct-12-22	Initiated	Jefferies	Hold	$260
Jul-11-22	Downgrade	Citigroup	Buy → Neutral	$310 → $250
Mar-02-22	Resumed	BofA Securities	Buy	$300
Feb-03-22	Upgrade	BTIG Research	Neutral → Buy	$320
Feb-02-22	Upgrade	UBS	Neutral → Buy	$325
Jan-31-22	Upgrade	Oppenheimer	Perform → Outperform	$300 → $275
Jul-21-21	Resumed	Cowen	Outperform	$285 → $310

Show Previous Ratings

Apr-17-25 08:52AM	4 Medical Product Stocks to Buy From a Challenging Industry (Zacks)
Apr-14-25 12:18PM	International Growth Drives GMED Stock Amid Fierce Competition (Zacks)
08:24AM	Bruker Stock May Benefit Following Its Investment in Ridom GmbH (Zacks)
Apr-13-25 08:38AM	Oakmark Bond Fund Q1 2025 Commentary (Seeking Alpha)
Apr-11-25 10:01AM	Bruker Debuts Fourier 80 Multinuclear Benchtop FT-NMR: Stock to Gain? (Zacks)
05:17AM	Loading…
Apr-10-25 05:17AM	Strength Seen in Insulet (PODD): Can Its 7.2% Jump Turn into More Strength? (Zacks) -5.01%
Apr-09-25 08:09AM	5 High-Flying Large-Cap Stocks to Buy Amid Tariff-Led Market Rout (Zacks) +7.16%
Apr-08-25 11:55AM	Oakmark Fixed Income Market Q1 2025 Commentary (Seeking Alpha)
10:02AM	PODD Stock Benefits From the Launch of Omnipod 5 in Canada (Zacks)
Apr-07-25 01:34PM	This Insulin Pump Maker Expands Into New Territory And Its Stock Shows Relative Strength (Investor's Business Daily)
07:07AM	Insulet Launches Omnipod® 5 Automated Insulin Delivery System in Canada, a Revolutionary New Technology for People Living with Type 1 Diabetes Ages Two Years and Above (PR Newswire)
Apr-03-25 02:25PM	Analyst Report: Insulet Corporation (Morningstar Research)
06:00AM	Insulet to Announce First Quarter 2025 Financial Results on May 8, 2025 (Business Wire)
Mar-31-25 09:30AM	DXCM Inks Deal With Nanowear to Boost CGM Application Beyond Diabetes (Zacks)
Mar-28-25 03:59PM	Baird Q4 2024 Small/Mid Cap Growth Equity Commentary (Seeking Alpha)
01:38PM	Loading…
01:38PM	Baird Q4 2024 Mid Cap Growth Strategy Commentary (Seeking Alpha)
Mar-27-25 10:50AM	Columbia Select Large Cap Growth Fund Q4 2024 Commentary (SeekingAlpha)
05:14AM	3 Reasons Investors Love Insulet (PODD) (StockStory)
Mar-24-25 08:09AM	Insulet Gains 62.9% in a Year: What's Driving the Stock? (Zacks)
Mar-21-25 12:36PM	PODD Stock Gains Following the Launch of Omnipod 5 in Australia (Zacks)
08:30AM	Artisan International Small-Mid Fund Q4 2024 Commentary (SeekingAlpha)
08:19AM	DGX Stock Set to Benefit From New Google Cloud Partnership (Zacks)
05:06AM	Patient Monitoring Stocks Q4 In Review: Insulet (NASDAQ:PODD) Vs Peers (StockStory)
Mar-20-25 12:41PM	PODD Stock to Gain From Favorable RADIANT Trial Results for Omnipod 5 (Zacks)
08:23AM	LendingTree and AMC Networks have been highlighted as Zacks Bull and Bear of the Day (Zacks)
05:54AM	Dexcom shares 15-day CGM data; Tandem posts Type 2 pivotal data (MedTech Dive)
Mar-19-25 04:01PM	Insulets RADIANT Trial Demonstrates Meaningful Glycemic Improvements with the Omnipod 5 Automated Insulin Delivery System Following Direct Transition from Multiple Daily Injections (Business Wire)
11:03AM	3 Tariff-Proof Medical Device Stocks to Watch Amid Trump's MAGA Slogan (Zacks)
Mar-18-25 04:32PM	Insulet Announces Pricing of Senior Notes Due 2033 (Business Wire)
01:51PM	Insulet Corporation (PODD): Among the Best Diabetes Stocks to Buy According to Billionaires (Insider Monkey)
10:35AM	Loading…
10:35AM	Insulet Chief Technology Officer Mark Field leaves (MedTech Dive)
07:35AM	Insulet Announces Proposed Financing Transactions (Business Wire)
06:05AM	Insulet Expands Omnipod 5 to Four More International Markets (Business Wire)
06:00AM	From Injections to Innovation Insulet to Present Results from a Multinational Randomized Trial of Direct Transition from Multiple Daily Injections to Omnipod 5 in Adults and Children with Type 1 Diabetes (Business Wire)
Mar-11-25 06:00AM	Insulet to Host Investor Day on June 5, 2025 (Business Wire)
Mar-07-25 09:41AM	Robinhood initiated, MongoDB downgraded: Wall Streets top analyst calls (TipRanks)
Feb-27-25 09:23PM	Analyst Report: Insulet Corporation (Morningstar Research)
06:49AM	Tandems insulin pump tech wins FDA nod for Type 2 diabetes (MedTech Dive)
04:05AM	Reflecting On Patient Monitoring Stocks Q4 Earnings: DexCom (NASDAQ:DXCM) (StockStory)
Feb-26-25 08:04AM	Insulet Sales Keep Rising (FX Empire)
Feb-25-25 02:52PM	Medtronic Stock Gets IBD Rating Lift (Investor's Business Daily) -5.93%
Feb-21-25 01:28PM	Insulet's Strong Q4 Highlights Surging Omnipod Demand And Growth Potential: Analyst (Benzinga)
10:45AM	Analyst Report: Insulet Corporation (Morningstar Research)
02:15AM	Insulet Corp (PODD) Q4 2024 Earnings Call Highlights: Record Revenue and Strategic Expansion ... (GuruFocus.com)
Feb-20-25 05:30PM	Compared to Estimates, Insulet (PODD) Q4 Earnings: A Look at Key Metrics (Zacks)
05:15PM	Insulet (PODD) Q4 Earnings and Revenues Top Estimates (Zacks)
04:35PM	Insulets (NASDAQ:PODD) Q4: Beats On Revenue, Quarterly Revenue Guidance Slightly Exceeds Expectations (StockStory)
04:33PM	Insulet: Q4 Earnings Snapshot (Associated Press Finance)
04:01PM	Insulet Reports Full Year 2024 Revenue Increase of 22% and Fourth Quarter 2024 Revenue Increase of 17% Year-Over-Year (Business Wire)
Feb-19-25 08:11AM	Insulet Earnings: What To Look For From PODD (StockStory)
Feb-14-25 09:15AM	Stay Ahead of the Game With Insulet (PODD) Q4 Earnings: Wall Street's Insights on Key Metrics (Zacks)
Jan-13-25 04:01PM	Insulet Launches Revolutionary Omnipod 5 in Five More Countries in Europe (Business Wire)
Jan-10-25 06:00AM	Insulet to Announce Fourth Quarter and Full Year 2024 Financial Results on February 20, 2025 (Business Wire)
Jan-07-25 12:23PM	Insulin Device Maker Has Analysts Turning Bullish (Investor's Business Daily)
Dec-31-24 07:15AM	Insulet price target raised to $300 from $270 at BTIG (TipRanks)
Dec-27-24 03:47PM	Heavy Interest in Insulets Insulin Delivery Device (FX Empire)
Dec-13-24 09:50AM	Why Insulet (PODD) is a Top Momentum Stock for the Long-Term (Zacks)
Dec-11-24 02:59PM	Inari Medical Stock Gets RS Rating Upgrade (Investor's Business Daily)
Dec-05-24 07:19AM	Insulet awarded $452M in EOFlow patent fight (MedTech Dive)
Dec-04-24 04:28PM	Insulet Successfully Defends its Intellectual Property Against EOFlow Co. in U.S. District Court (Business Wire)
Dec-03-24 02:51PM	Novocure Stock Earns 96 RS Rating (Investor's Business Daily)
Nov-29-24 09:45AM	Here's Why Insulet (PODD) is a Strong Growth Stock (Zacks)
Nov-21-24 08:27AM	Insulet adds Abbotts FreeStyle Libre 2 Plus to Omnipod 5s compatibility roster (Medical Device Network)
Nov-20-24 08:30AM	Insulet Announces Omnipod 5 System is Now Compatible with Abbott's FreeStyle Libre 2 Plus Sensor in the U.S. (Business Wire)
Nov-15-24 06:00AM	Insulet to Present at Upcoming Investor Conferences (Business Wire)
Nov-12-24 09:45AM	Why Insulet (PODD) is a Top Growth Stock for the Long-Term (Zacks)
06:45AM	Insulet price target raised to $317 from $234 at Morgan Stanley (TipRanks)
Nov-11-24 05:21PM	Insulet CEO on earnings, GLP-1 and election impact (CNBC TV)
Nov-08-24 04:39PM	S&P 500 Gains and Losses Today: Axon Shares Surge as Taser Maker Tops Estimates (Investopedia) +9.40%
04:11PM	Insulet Soars Out Of Buy Zone As 'Beat-And-Raise Cadence' Continues (Investor's Business Daily)
01:40PM	Top Stock Movers Now: Axon Enterprise, Sweetgreen, Akamai Technologies, and More (Investopedia)
12:55PM	Costco Stock Breaks Out Past Buy Point, Reaches All-Time High (Investor's Business Daily)
06:01AM	Tandem, Insulet tout Type 2 expectations as tech attracts new users (MedTech Dive)
02:27AM	Insulet Corp (PODD) Q3 2024 Earnings Call Highlights: Record Revenue Growth and Strategic Expansions (GuruFocus.com)
Nov-07-24 05:30PM	Insulet (PODD) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
05:15PM	Insulet (PODD) Q3 Earnings and Revenues Top Estimates (Zacks)
04:10PM	Insulet: Q3 Earnings Snapshot (Associated Press Finance)
04:01PM	Insulet Reports Third Quarter 2024 Revenue Increase of 26% Year-Over-Year (25% Constant Currency1) (Business Wire)
Nov-04-24 09:16AM	Stay Ahead of the Game With Insulet (PODD) Q3 Earnings: Wall Street's Insights on Key Metrics (Zacks)
Nov-01-24 06:00AM	Insulet Announces Array of Activities to Support National Diabetes Awareness Month and World Diabetes Day in November (Business Wire)
Oct-31-24 10:02AM	Insulet (PODD) Earnings Expected to Grow: Should You Buy? (Zacks)
Oct-30-24 01:06PM	Insulet rolls out iPhone app for Omnipod 5 insulin pump in US (Medical Device Network)
Oct-29-24 04:01PM	Omnipod 5 App for iPhone Now Fully Available in the United States (Business Wire)
Oct-28-24 02:08PM	Here Is Why Analysts See More Growth After Meta's Impressive Gains (Investor's Business Daily)
Oct-15-24 04:01PM	Solventum Stock Earns 81 RS Rating (Investor's Business Daily)
07:37AM	Insulet price target raised to $260 from $250 at BTIG (TipRanks)
Oct-11-24 12:32PM	Is Insulet Corporation (NASDAQ:PODD) The Top Stock With Improving Technical Ratings According To Piper Sandler? (Insider Monkey)
Oct-10-24 09:00AM	National Campaign Launches to Combat Diabetes Stigma Using Comedy (PR Newswire)
Oct-09-24 05:53PM	Insulet Corp (PODD) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and Raised Guidance (GuruFocus.com)
08:55AM	Heres Why ClearBridge Growth Strategy Increased its Position in Insulet Corporation (PODD) (Insider Monkey)
Oct-07-24 03:04PM	FMR LLC Bolsters Position in Insulet Corp with Strategic Share Acquisition (GuruFocus.com)
Oct-01-24 08:07AM	Fidelity Growth Strategies Fund Trimmed Insulet Corporation (PODD) to Manage the Position Size (Insider Monkey)
Sep-30-24 06:00AM	Insulet to Announce Third Quarter 2024 Financial Results on November 7, 2024 (Business Wire)
Sep-12-24 01:01PM	Insider Sale: Director Timothy Scannell Sells 5,000 Shares of Insulet Corp (PODD) (GuruFocus.com)
Sep-07-24 01:16AM	Insulets (PODD) Sales And Margins Surpassed Expectations (Insider Monkey)
Sep-05-24 07:22PM	Analyst Report: Insulet Corporation (Morningstar Research)
Sep-04-24 05:00PM	S&P 500 Gains and Losses Today: Dollar Tree Stock Tumbles After Earnings Miss (Investopedia)
Aug-30-24 10:35AM	Analyst Report: Insulet Corporation (Morningstar Research)
07:20AM	Why Insulet Stock Was Zooming Higher This Week (Motley Fool)
01:46AM	Insider Sale at Insulet Corp (PODD): SVP & Chief Technology Officer Mark Field Sells Shares (GuruFocus.com)

Insulet Corp. is a medical device company, which engages in the development, manufacture, and marketing of an insulin infusion system for people with insulin-dependent diabetes. It specializes in diabetes supplies, including the OmniPod System, as well as other diabetes related products and supplies such as blood glucose testing supplies, traditional insulin pumps, pump supplies, and pharmaceuticals. The company was founded by John L. Brooks III and John T. Garibotto in July 2000 and is headquartered in Acton, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Frederick Wayne A.I.	Director	Mar 25 '25	Sale	275.00	1,825	501,875	3,231	Mar 26 04:22 PM
Frederick Wayne A.I.	Director	Mar 25 '25	Proposed Sale	275.00	1,825	501,875		Mar 25 10:30 AM
Benjamin Eric	EVP, CPXO	Mar 03 '25	Option Exercise	56.52	5,146	290,873	20,906	Mar 04 04:09 PM
Benjamin Eric	EVP, CPXPO	Jan 21 '25	Option Exercise	65.00	5,075	329,898	23,777	Jan 22 04:10 PM
Benjamin Eric	EVP, CPXPO	Jan 21 '25	Sale	280.00	12,394	3,470,320	11,383	Jan 22 04:10 PM
Benjamin Eric	Officer	Jan 21 '25	Proposed Sale	280.00	12,394	3,470,320		Jan 21 10:56 AM
Benjamin Eric	EVP, CPXPO	Dec 16 '24	Sale	267.60	4,362	1,167,271	18,702	Dec 17 04:14 PM
Benjamin Eric	Officer	Dec 16 '24	Proposed Sale	267.60	4,362	1,167,271		Dec 16 10:38 AM
Budden Lauren	Group VP, CAO and Controller	Dec 10 '24	Sale	275.62	915	252,192	5,733	Dec 11 04:00 PM
Budden Lauren	Officer	Dec 10 '24	Proposed Sale	275.62	915	252,194		Dec 10 05:18 PM
BORIO LUCIANA	Director	Nov 12 '24	Sale	274.80	508	139,598	2,790	Nov 13 04:01 PM
BORIO LUCIANA	Director	Nov 12 '24	Proposed Sale	274.81	508	139,602		Nov 12 04:01 PM
Hopfield Jessica	Director	Sep 11 '24	Option Exercise	29.87	7,628	227,848	34,545	Sep 12 04:07 PM
Hopfield Jessica	Director	Sep 11 '24	Sale	225.26	7,628	1,718,283	26,917	Sep 12 04:07 PM
Scannell Timothy J	Director	Sep 10 '24	Sale	225.84	5,000	1,129,200	30,586	Sep 11 04:13 PM
Hopfield Jessica	Director	Sep 11 '24	Proposed Sale	225.26	7,628	1,718,283		Sep 11 03:40 PM
Field Mark N	SVP & Chief Technology Officer	Sep 09 '24	Sale	220.87	1,383	305,463	9,761	Sep 10 04:16 PM
Budden Lauren	Group VP, CAO and Controller	Sep 09 '24	Sale	221.41	1,506	333,443	6,609	Sep 10 04:15 PM
Scannell Timothy J	Director	Sep 10 '24	Proposed Sale	225.84	5,000	1,129,210		Sep 10 02:27 PM
Field Mark N	Officer	Sep 09 '24	Proposed Sale	220.87	1,383	305,465		Sep 09 04:50 PM
Budden Lauren	Officer	Sep 09 '24	Proposed Sale	221.41	1,506	333,436		Sep 09 01:20 PM
Singh Prem	SVP, Global Operations	Aug 30 '24	Sale	202.27	1,824	368,940	3,656	Sep 03 04:30 PM
Singh Prem	Officer	Aug 30 '24	Proposed Sale	202.27	1,824	368,938		Aug 30 03:22 PM
Chadwick Ana Maria	EVP, CFO & Treasurer	Aug 29 '24	Buy	206.00	100	20,600	13,314	Aug 29 04:17 PM
Field Mark N	SVP & Chief Technology Officer	Aug 28 '24	Sale	203.00	1,387	281,561	11,347	Aug 29 04:14 PM
Field Mark N	Officer	Aug 28 '24	Proposed Sale	203.00	1,387	281,561		Aug 28 04:02 PM
Field Mark N	SVP & Chief Technology Officer	Jun 14 '24	Sale	199.96	1,500	299,940	12,875	Jun 17 04:11 PM
Scannell Timothy J	Director	Jun 10 '24	Sale	190.51	7,000	1,333,570	35,586	Jun 11 04:12 PM
Field Mark N	SVP & Chief Technology Officer	Jun 10 '24	Sale	190.43	2,131	405,806	14,375	Jun 11 04:11 PM
BORIO LUCIANA	Director	Jun 04 '24	Sale	182.58	360	65,729	3,298	Jun 05 04:13 PM
Scannell Timothy J	Director	May 28 '24	Option Exercise	32.33	18,267	590,595	45,886	May 29 04:04 PM
Scannell Timothy J	Director	May 28 '24	Sale	180.90	3,300	596,970	42,586	May 29 04:04 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

PODD

Insulet Corporation

Upgrade your FINVIZ experience